GSK), Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY) to expand the production of bird flu vaccines amid an ongoing outbreak among poultry and livestock that has led to fears of a potential human-to ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

GSK said at an R&D update in the summer that it expects to have two mRNA candidates in clinical trials within 12 months and six within the next four years, including seasonal flu shots.

Moderna, Pfizer, and a partnership between GSK and CureVac are reportedly working ... and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

GSK’s marketed vaccines target infectious diseases at every stage of life, protecting people from meningitis, shingles, respiratory syncytial virus (RSV), flu, polio and many more. Every day ...

As of Monday, there had been 66 confirmed human cases of H5N1 bird flu in the U.S. since 2024 and 67 since 2022, according to Centers for Disease Control and Prevention data. Pfizer (PFE) and GSK ...